Preferred Label : Peroxisome biogenesis disorder 11b;
Symbol : PBD11B;
CISMeF acronym : PBD11B;
Type : Phenotype, molecular basis known;
Description : The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum
disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum
(ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the
NALD and IRD presentation is variable and may include developmental delay, hypotonia,
liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment.
Children with the NALD presentation may reach their teens, and those with the IRD
presentation may reach adulthood (summary by Waterham and Ebberink, 2012). For a complete
phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD),
see 601539. Individuals with mutations in the PEX13 gene have cells of complementation
group 13 (CG13, equivalent to CGH). For information on the history of PBD complementation
groups, see 214100.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the peroxisome biogenesis factor 13 gene (PEX13, 601789.0002);
Laboratory abnormalities : Normal dihydroxyacetonephosphate acyltransferase (DHAPAT) activity in fibroblasts; Residual beta-oxidation activity in fibroblasts; Scarce peroxisomes in fibroblasts;
Prefixed ID : #614885;
Origin ID : 614885;
UMLS CUI : C3554001;
Automatic exact mappings (from CISMeF team)
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)